Premium
In vitro antimicrobial activity of seven adjuvants against common pathogens associated with canine otitis externa
Author(s) -
Chan Wei Yee,
Khazandi Manouchehr,
Hickey Elizabeth E.,
Page Stephen W.,
Trott Darren J.,
Hill Peter B.
Publication year - 2019
Publication title -
veterinary dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.744
H-Index - 60
eISSN - 1365-3164
pISSN - 0959-4493
DOI - 10.1111/vde.12712
Subject(s) - antimicrobial , otitis , medicine , in vitro , microbiology and biotechnology , biology , surgery , biochemistry
Background An antibiotic adjuvant is a chemical substance used to modify or augment the effectiveness of primary antimicrobial agents against drug‐resistant micro‐organisms. Its use provides an alternative approach to address the global issue of antimicrobial resistance and enhance antimicrobial stewardship. Hypothesis/Objectives To determine the antimicrobial activity of a panel of potential antimicrobial adjuvants against common pathogens associated with canine otitis externa (OE). Animals/Isolates A number of type strains and clinical isolates (n = 110) from canine OE were tested including Staphylococcus pseudintermedius, β‐haemolytic Streptococcus spp., Pseudomonas aeruginosa , Proteus mirabilis and Malassezia pachydermatis . Methods and materials Antimicrobial activities of monolaurin, monocaprin, N ‐acetylcysteine (NAC), polymyxin B nonapeptide, Tris‐EDTA, Tris‐HCL and disodium EDTA were tested using microdilution methodology according to CLSI guidelines. Results N ‐acetylcysteine, Tris‐EDTA and disodium EDTA had antimicrobial activity against both type strains and otic pathogens. The other adjuvants tested had limited to no efficacy. NAC had a minimal inhibitory concentration (MIC) range of 2,500–10,000 μg/mL for the various organisms. Pseudomonas aeruginosa isolates were eight times more susceptible to disodium EDTA in the presence of Tris‐HCL in comparison to disodium EDTA alone. Malassezia pachydermatis isolates were most susceptible to Tris‐EDTA (MIC 90 = 190/60 μg/mL) and disodium EDTA (MIC 90 = 120 μg/mL). Conclusions and clinical relevance N ‐acetylcysteine, Tris‐EDTA and disodium EDTA have intrinsic antimicrobial activity and represent promising adjuvants that could be used to enhance the efficacy of existing antibiotics against Gram‐negative and multidrug‐resistant bacterial infections. These agents could be combined with other antimicrobial agents in a multimodal approach for mixed ear infections in dogs.